Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17719364 | 0.77 | — | — | |
| SCHEMBL25852149 | 0.75 | KDM4E (0.32) | GAA | |
| SCHEMBL25852170 | 0.75 | DGAT1 (0.33) | — | |
| SCHEMBL23628601 | 0.71 | PDE10A (0.37) | PDE10A | |
| SCHEMBL19397864 | 0.71 | DGAT1 (0.36) | — | |
| SCHEMBL15340423 | 0.71 | DGAT1 (0.35) | — | |
| SCHEMBL17238976 | 0.69 | MAP4K4 (0.44) | — | |
| SCHEMBL859975 | 0.61 | PDE10A (0.53) | PDE10A | |
| SCHEMBL31521282 | 0.60 | PDE10A (0.35) | PDE10A | |
| SCHEMBL15903656 | 0.60 | PARP1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239830-A1 | METHODS OF PREPARING CARBANUCLEOSIDES USING AMIDES | ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) | 2024-07-18 | — | — | US | disclosed |
| US-11697666-B2 | Methods of preparing carbanucleosides using amides | GILEAD SCIENCES, INC. (US) | 2023-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11697666-B2 | Methods of preparing carbanucleosides using amides | NCL, DUT, POLN | PDE10A 3144/4885GAA 408/4885 |
| US-20240239830-A1 | METHODS OF PREPARING CARBANUCLEOSIDES USING AMIDES | NCL, DUT, POLN | PDE10A 3144/4885GAA 408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.